Scholars Central

Conference abstractPublished 20 Jun 2016

Novel cholesterol based siRNA lipoplexes with and without PEG-modification: Characterization and in vitro cytotoxicity studies

Authors: Saffiya Habib, Mario Ariatti, Moganavelli Singh

University of KwaZulu-Natal, South Africa

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Cationic liposomes have potential in carrying small interfering RNA (siRNA) molecules as gene medicines. However, unfavorable liposome-serum interactions often limit their efficacy. In order to address this concern, liposome-stabilizing agents, cholesterol (Chol) and polyethylene glycol (PEG) were incorporated in the design of new liposome-siRNA systems. The helper lipid, Chol, was combined in equimolar quantities with the cytofectin, N,N-dimethylaminopropylamidosuccinylc holesterylformylhydrazide (MS09), to give unilamellar vesicles. For PEG-modification, distearoylphosphatidylethanolamine poly(ethylene glycol) 2000 was added at 2 mol %. Electrostatic association of liposomes with siRNA was followed in band shift and fluorescence quenching assays. Liposome-siRNA complexes (lipoplexes) were observed as globular aggregates by cryo-transmission electron microscopy. Characterization of lipoplexes by Zeta-potential Nanoparticle Tracking Analysis (Z-NTA) showed that lipoplex size and zeta potential were dependent on both liposome composition and the MS09:siRNA (w/w) mixing ratio. siRNA within lipoplexes resisted serum-induced damage at MS09:siRNA (w/w) ratios of 12:1-32:1. The effects of lipoplexes on cell growth were evaluated with a non-targeting siRNA sequence in transformed and non-transformed human cell lines. MTT and alamarBlueÃ?® assays showed that MCF-7 and HEK293 cells retained at least 78% viability at final siRNA and lipid concentrations of 57 nM and 29-60 Ã?¼M, respectively. In general, cell survival profiles of MS09/Chol and MS09/ Chol/PEG liposomes compared favorably with that of LipofectamineâÂ?¢ 3000 and control formulations which contained the conventional helper lipid, dioleoylphosphatidylethanolamine (DOPE). At present, the siRNA delivery capability of liposomes is under assessment and the most promising formulations will be applied to the delivery of oncogene-specific siRNA in gene silencing experiments.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Saffiya Habib”
  • BylineArticles whose byline prints “Mario Ariatti”
  • BylineArticles whose byline prints “Moganavelli Singh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels